noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

Direct Relief Foundation

“We Are the Women We Serve”: Inside Birth Detroit’s Mission to Support[...]
FedEx Corporation

FedEx Earns Top Honors at the 2026 Supply Chain Asia Awards For[...]
Cytokinetics Incorporated

MYQORZO (aficamten) Receives ASMR III Rating from the HAS (French[...]

Healthcare

X-Chem Inc

07/13/2016 | Press release | Archived content

X‐Chem Marks the Spot for Bayer in Sweetened Drug Discovery Deal

July 13 2016 | BIOWORLD TODAY | Bayer AG and privately held X-Chem Inc. expanded their global drug discovery collaboration, initiated in 2012, to encompass the entire bandwidth of therapeutic areas and target classes from Bayer's R&D pipeline.

X-Chem Inc published this content on July 13, 2016, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on November 10, 2026 at 10:38 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]

Back

View original format